SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : URMD -- Huge market potential
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rick Riebesell who wrote (201)1/27/1998 11:33:00 AM
From: Hugh A. McWhorter  Read Replies (1) of 369
 
thanks for the post, Rick. I had read all of this too. Projections are not part of a 10-Q because they do not fall within the discipline of reporting quarterly historic results. Seems to me that the message of the section of the 10-Q which you cite could have been reduced to one simple sentence. "The company needs sales to survive."

That one issue is why I backed off of going into a covered straddle with this stock. I do not recall if it was here or elsewhere I posted that about two weeks ago is someone bought the stock, sold a July $5 call and a July $5 put your net invested cost is 69 cents. If it runs as Individual Investor predicts one turns 69 cents into $5 in six months. The downside to all of this was no sales--just future guesses by the company of the need for their product and the assumption the public will buy it. So if the stock tanked you get stuck with a $4 worthless stock and to add insult to injury, you get put for $5 which also is worthless.

Best regards, Hugh
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News